Optochemical retinal prosthesis for vision restoration

Overview

This work addresses limitations of electrical neural prostheses by developing a solid-state optochemical platform for localized neurotransmitter delivery to the retina. The system integrates nanoscale patterned membranes, light-responsive molecular valves, and synaptic adhesion engineering to enable spatiotemporal control of glutamate release, with applications to vision restoration in photoreceptor degenerative diseases.

Methods and approach

A planar solid-state device incorporating a nanopatterned membrane coupled to a neurotransmitter reservoir was engineered to support diffusion- and pressure-driven molecular translocation. Spatiotemporal control was achieved through integration of a spiropyran-functionalized polymer nanovalve that modulates pore permeability in response to light stimulation. Biocompatibility and functional efficacy were evaluated in primary neuronal cultures, ex vivo mouse retinal tissue, and non-human primate retinal explants. Pre- and post-synaptic adhesion molecule characterization was performed to establish hybrid synaptic interfaces. A subretinal injection platform with bioimpedance-guided feedback was developed for precise viral delivery of synaptic adhesion molecules.

Results

The nanovalve system blocked up to 96% of glutamate flux when deactivated and enabled on-demand release at physiologically comparable rates upon light activation. The device reproducibly elicited glutamate-mediated neuronal activation across primary cultures and degenerated retinal tissue preparations. Synaptic adhesion molecules demonstrated synaptogenic activity in primary neurons, and the injection platform successfully guided precise viral delivery in retinal tissue.

Implications

The platform establishes a biomimetic chemical alternative to electrical, optogenetic, and electronic prosthetic approaches for restoring visual function in irreversible photoreceptor loss conditions such as retinitis pigmentosa and age-related macular degeneration. By combining light-controlled molecular release with endogenous synaptic signaling mechanisms, the technology addresses fundamental limitations of existing neural stimulation modalities in terms of spatial resolution, biocompatibility, and physiological fidelity. The integrated approach with synaptic engineering and guided delivery systems provides a scalable foundation for advanced neuroprosthetic strategies applicable to broader brain-machine interface development.